Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
30
31
1
2
3
4
5
6
7
8
9
11
12
13
16
17
18
19
21
23
24
25
26
27
29
30
31
1
The International Meeting for Simulation in Healthcare
2015-01-10 - 2015-01-14    
All Day
Registration is Open! Please join us on January 10-14, 2015 for our fifteenth annual IMSH at the Ernest N. Morial Convention Center in New Orleans, Louisiana. Over [...]
Finding Time for HIPAA Amid Deafening Administrative Noise
2015-01-14    
1:00 pm - 3:00 pm
January 14, 2015, Web Conference 12pm CST | 1pm EST | 11am MT | 10am PST | 9am AKST | 8am HAST Main points covered: [...]
Meaningful Use  Attestation, Audits and Appeals - A Legal Perspective
2015-01-15    
2:00 pm - 3:30 pm
Join Jim Tate, HITECH Answers  and attorney Matt R. Fisher for our first webinar event in the New Year.   Target audience for this webinar: [...]
iHT2 Health IT Summit
2015-01-20 - 2015-01-21    
All Day
iHT2 [eye-h-tee-squared]: 1. an awe-inspiring summit featuring some of the world.s best and brightest. 2. great food for thought that will leave you begging for more. 3. [...]
Chronic Care Management: How to Get Paid
2015-01-22    
1:00 pm - 2:00 pm
Under a new chronic care management program authorized by CMS and taking effect in 2015, you can bill for care that you are probably already [...]
Proper Management of Medicare/Medicaid Overpayments to Limit Risk of False Claims
2015-01-28    
1:00 pm - 3:00 pm
January 28, 2015 Web Conference 12pm CST | 1pm EST | 11am MT | 10am PST | 9AM AKST | 8AM HAST Topics Covered: Identify [...]
Events on 2015-01-10
Events on 2015-01-20
iHT2 Health IT Summit
20 Jan 15
San Diego
Events on 2015-01-22
Latest News

Factors Predicting Poor Locoregional Control in Tongue Cancer

In patients with pT1-2N0 oral tongue squamous cell carcinoma undergoing partial glossectomy and elective neck dissection, inferior locoregional control (LRC) was associated with depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins. These retrospective findings, presented at the 2024 ASTRO Multidisciplinary Head and Neck Cancers Symposium, remained significant even in cases with final negative tumor bed margins.At a median follow-up of 45.6 months, the all-comer patient population exhibited 3-year locoregional control (LRC) and overall survival (OS) rates of 88.0% and 92.5%, respectively. Among patients with pT1 disease, these rates were 92.0% and 95.2%, while in those with pT2 disease, the rates were 85.0% and 90.5%.

However, during the multivariate analysis, individuals with positive glossectomy margins exhibited poorer locoregional control (HR, 6.66; 95% CI, 1.60-27.78; P = .009). Lymphovascular space invasion (HR, 6.90; 95% CI, 1.42-33.65; P = .02) and depth of invasion (HR, 1.31; 95% CI, 1.06-1.63; P = .01) were also correlated with diminished locoregional control.

The lead study author, Michael Modzelewski, MD, along with the co-investigators, stated in a poster presented at the meeting, “Patients with these risk factors may be considered for adjuvant radiotherapy to optimize disease control.”

Individuals with early-stage tongue squamous cell carcinoma typically do not undergo adjuvant radiation due to their low recurrence risk. After surgery, the status of the primary glossectomy specimen margin has been observed to have a stronger correlation with local recurrence than the status of additional tumor bed margins, as stated by the authors.

The investigators aimed to identify the pathological factors associated with locoregional recurrence in patients with early-stage tongue squamous cell carcinoma who underwent surgery alone. Additionally, they explored the impact of a positive glossectomy specimen margin on disease control concerning final negative tumor bed margins.

The research included 110 patients diagnosed with pT1-2N0 oral tongue squamous cancer, adhering to the American Joint Committee on Cancer (AJCC) 8th edition criteria. These individuals underwent partial glossectomy and elective dissection from 2015 to 2021, excluding adjuvant radiation. Pathology reports were examined for factors such as tumor size, depth of invasion, glossectomy specimen margin, final tumor bed margin status, and perineural or lymphovascular space invasion. Individuals with positive final margins or a history of head and neck radiation were excluded.

The Kaplan-Meier method was employed to estimate locoregional control (LRC) and overall survival (OS), with a Cox proportional hazards model identifying prognostic factors for LRC in multivariate analysis.

Concerning baseline characteristics, the median age was 52 years, with the majority being male (54.5%) and having pT2 stage disease (58.2%). There were 33 lymph nodes dissected on average, and the median tumor size measured 16 mm, with a depth of invasion reaching 5 mm.

The majority of patients did not exhibit perineural invasion (84.7%), while 3.6% had lymphovascular space invasion. Positive glossectomy specimen margins were observed in 8.2% of cases.

Further findings revealed that among patients with positive glossectomy specimen margins and those without, the 3-year locoregional control (LRC) rates were 66.7% and 89.5%, respectively. Similarly, the rates were 0.0% for individuals with lymphovascular space invasion and 89.4% for those without. Among the 8 patients experiencing regional failure, 5 had recurrence in the ipsilateral neck alone (62.5%), 2 in the bilateral neck (25.0%), and 1 with isolated contralateral neck recurrence (12.5%).